Diabetes Therapeutics Market Worth $91+ Billion, Globally, by 2028 at 6+% CAGR | The Insight Partners

NEW YORK, Oct. 19, 2022 /PRNewswire/ -- The Insight Partners published latest research study on "Diabetes Therapeutics Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 – COVID-19 Impact and Global Analysis – by product, and geography", the global diabetes therapeutic market size is expected to grow from USD 58.46 billion in 2021 to USD 91.73 billion by 2028, with an estimated CAGR of 6.8% from 2022 to 2028.

Download Sample PDF Brochure of Diabetes Therapeutics Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00003748/

Global Diabetes Therapeutics Market Report Scope, Segmentations, Regional & Country Scope:

Browse key market insights spread across 150 pages with list of tables & list of figures from the report, "Diabetes Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Injectables, Oral-Antidiabetic Drugs, and Others) and Geography" in detail along with the table of contents: https://www.theinsightpartners.com/reports/diabetes-therapeutic-market

Global Diabetes Therapeutics Market: Competition Landscape and Key Developments

Leading business players in the diabetes therapeutics market include AstraZeneca, Boehringer Ingelheim International GmbH, Eli Lilly, GlaxoSmithKline Plc, Merck Sharp and Dohme Corp, Novartis AG, Novo Nordisk A/S, Sanofi, Takeda Pharmaceutical Company Limited, and Pfizer Inc. Market players are adopting various inorganic growth strategies to increase diabetes therapeutic market share and achieve a competitive advantage.

In 2019, Mankind Pharmaceuticals signed a collaborative marketing agreement with Glenmark Pharmaceuticals to market remoglifozin, an antidiabetic drug, in India. This has allowed both firms to expand their business in Asia Pacific.

Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00003748/

In 2018, Cipla collaborated with Novartis and Johnson & Johnson to market their antidiabetic drugs. This collaboration has led to business expansion of the firm, thereby strengthening its market position.

Diabetes is a chronic, life-threatening disease with no known cure. As per the World Health Organization, there are over 400 million people with diabetes worldwide, and its treatment constitutes around 12% of the total healthcare expenditure on a global scale. It has emerged as a global epidemic and affected millions worldwide. The significant growth of the diabetes therapeutic market can be attributed to factors such as the rising prevalence of diabetes and an increasing number of programs initiated by various health organizations related to health awareness. The factors mentioned above are catalyzing the global diabetes therapeutic market growth in the current times and are also foreseen to drive the global diabetes therapeutic market through 2028.

The high demand of diabetes treatment products from the Type-1 diabetes population is driving the diabetes therapeutic market. For instance, according to the International Diabetes Federation, diabetes patients spent US$ 966 billion in 2021, of which a major chunk was spent by Type-1 diabetes patients on insulin drugs. Few Type-2 diabetes patients also depend on insulin. Although only 10% of the diabetes population is Type-1, their insulin intake is higher in them. The demand for insulin is driven by an increase in awareness about the benefits of insulin for diabetes patients, especially in emerging economies. Moreover, rapid development in insulin delivery systems, drug and analog development by major companies, and the rise in geriatric and obese population are fueling the growth of the insulin market.

Speak to Research Expert: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00003748

North America dominates the global diabetes therapeutics market, owing to the high prevalence of diabetes in the region because of the sedentary lifestyle. The market in the US is expected to grow significantly during the forecast period, owing to a high prevalence of obesity and a rise in awareness regarding diabetes care in the country. North America remained the largest diabetes therapeutic market for diabetes therapeutics, primarily due to an increase in FDA approvals for various drugs and injections in the US. For instance, in January 2020, Novo Nordisk announced that the US Food and Drug Administration (FDA) approved Fiasp (insulin aspart injection) 100 u/mL for use as a new mealtime insulin option for children with diabetes.

Diabetes and uncontrolled hyperglycemia are risk factors for poor outcomes in patients with COVID-19, including an increased risk of severe illness or death. People with diabetes have a weaker immune system, the COVID-19 complication aggravates the condition, and the immune system gets weaker very fast. People with diabetes are more likely to get into serious complications than normal people. Hence, the COVID-19 pandemic significantly impacted the diabetes therapeutics market.

The report summarizes detailed information by top players such as AstraZeneca, Boehringer Ingelheim International GmbH, Eli Lilly, GlaxoSmithKline Plc, Merck Sharp and Dohme Corp, Novartis AG, Novo Nordisk A/S, Sanofi, Takeda Pharmaceutical Company Limited, and Pfizer Inc. Several other major companies were studied and analyzed during this research study to get a holistic view of the global diabetes therapeutic market and its ecosystem.

Quickly Purchase Premium Copy of Diabetes Therapeutics Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00003748/

Go through further research published by The Insight Partners:

Wifi-as-a-Service Market - The global wi-fi as a service market size is projected to grow from US$ 3.66 billion in 2021 to US$ 13.34 billion by 2028; it is expected to grow at a CAGR of 19.5% during 2022–2028.

Sound Recognition Market - The global sound recognition market size is projected to grow from US$ 3.84 billion in 2021 to US$ 9.70 billion by 2028; it is expected to grow at a CAGR of 14.5% from 2022 to 2028.

Network Transformation Market - The global network transformation market size is expected to grow from US$ 19.27 billion in 2021 to US$ 175.34 billion by 2028 at a CAGR of 40.6% between 2022 and 2028.

Molded Interconnect Devices (MID) Market - The global molded interconnect device (MID) market size is expected to grow from US$ 1,203.5 million in 2021 to US$ 2,711.9 million by 2028 at a CAGR of 14.5% from 2022 to 2028.

Digital Education Market - The global digital education market size is expected to grow from US$ 11.62 billion in 2021 to US$ 54.95 billion by 2028 at a CAGR of 26.1% between 2022 and 2028.

Data Collection and Labeling Market - The global data collection and labeling market size is expected to grow from US$ 1.82 billion in 2021 to US$ 9.07 billion by 2028 at a CAGR of 27.2% between 2022 and 2028.

Customer Data Platform Market - The global customer data platform market size is expected to grow from US$ 2,672.5 Mn in 2021 to US$ 14,847.1 Mn by 2028 at a CAGR of 28.2% between 2022 and 2028.

Vehicle Tracking Systems Market - The global vehicle tracking systems market size is expected to grow from US$ 13.67 billion in 2021 to US$ 23.70 billion by 2028; it is expected to grow at a CAGR of 8.7% from 2022 to 2028.

Autonomous Last Mile Delivery Market - The global autonomous last mile delivery market size is expected to grow from US$ 57.67 billion in 2021 to US$ 68.95 billion by 2028; it is expected to register a CAGR of 3.0% from 2022 to 2028.

ISDN Modem Market - The global ISDN modem market size was valued US$ 982.97 thousand in 2022, it is estimated to register a CAGR of -80.6% from 2022 to 2024.

Semiconductor Bonding Market - The global semiconductor bonding market size was valued US$ 669.48 million in 2022, it is estimated to grow at a CAGR of 8.2% from 2022 to 2028.

Recycled Ocean Plastics Market - The global recycled ocean plastics market size was valued at US$ 14,432.91 million in 2022, it is expected to grow at a CAGR of 8.5% from 2022 to 2028.

EDM Wire Market - The global EDM wire market size is expected to grow from US$ 1,497.50 million in 2022, it is estimated to grow at a CAGR of 7.6% from 2022 to 2028.

Seam Welding Machine Market - The global seam welding machine market size was valued US$ 1,142.87 million in 2022, it is estimated to grow at a CAGR of 4.0% from 2022 to 2028.

Electric Coolant Pump Market - The global electric coolant pump market size was valued US$ 467.46 million in 2022, it is estimated to grow at a CAGR of 16.8% from 2022 to 2028.

Smart Manufacturing Market - The global smart manufacturing market size was valued US$ 258.72 billion in 2022, it is estimated to grow at a CAGR of 6.0% from 2022 to 2028.

Respiratory Care Devices Market - The global respiratory care devices market size is expected to grow from US$ 18,114.31 million in 2021 to US$ 32,761.82 million by 2028; it is estimated to register a CAGR of 8.9% from 2021 to 2028.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/diabetes-therapeutics-market
Industry Research: https://www.einpresswire.com/newsroom/the_insight_partners/ | https://www.whatech.com/og/markets-research/companies/the-insight-partners-2019-05-20

Logo: https://mma.prnewswire.com/media/1586348/The_Insight_Partners_Logo.jpg